MedTrace Logo

Plasma Level of Various Omega-3 Lipids

NCT03118999 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2018-09-20

No results posted yet for this study

Summary

The primary objective of this study is to evaluate the pharmacokinetic properties of 3 OM3 oils after a single-dose administration in healthy volunteers

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

OM3-FFA

Comparison of the effects of OM3-FFA versus OM3-MAG and OM3-EE in a crossover design

DIETARY_SUPPLEMENT

OM3-MAG

Comparison of the effects of OM3-MAG versus OM3-FFA and OM3-EE in a crossover design

DIETARY_SUPPLEMENT

OM3-EE

Comparison of the effects of OM3-EE versus OM3-FFA and OM3-MAG in a crossover design

Sponsors & Collaborators

  • Société des Produits Nestlé (SPN)

    lead INDUSTRY

Principal Investigators

  • Bernard Cuénoud · Nestec Ltd.

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-02-28
Primary Completion
2017-04-30
Completion
2017-08-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03118999 on ClinicalTrials.gov